Vicki Brown
Family Medicine · Willard, OHNPI 1952315905
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $686 and has fallen 97.2% since, to $19 in 2024.
Across 78 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$212
- Novo Nordisk$191
- Amgen$122
- GSK$113
- AbbVie$91
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$70
- plus $472 from 17 others
What the payments were for
- Food & beverage$1,22396%
- Education$494%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $212 |
| Novo Nordisk | 7 | $191 |
| Amgen | 8 | $122 |
| GSK | 7 | $113 |
| AbbVie(2 entities) | 5 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| Amarin Pharma, Inc. | 4 | $62 |
| Lilly USA, LLC | 4 | $52 |
| Pfizer | 4 | $45 |
| Astellas Pharma US Inc | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Johnson & Johnson | 3 | $38 |
| Tolmar, Inc. | 1 | $31 |
| Merck | 2 | $27 |
| Radius Health, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Mylan Specialty L.p. | 1 | $16 |
| Novartis | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Bayer | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Cranial Technologies, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Saxenda$120
How this compares
$1,271 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 50 | $382 |
| Duloxetine Hcl | 20 | $371 |
| Potassium Chloride | 12 | $293 |
| Levothyroxine Sodium | 40 | $281 |
| Losartan Potassium | 25 | $246 |
| Lisinopril | 26 | $217 |
| Warfarin Sodium | 11 | $212 |
| Metformin Hcl | 17 | $208 |
| Alendronate Sodium | 28 | $199 |
| Amlodipine Besylate | 27 | $182 |
| Rosuvastatin Calcium | 11 | $162 |
| Pantoprazole Sodium | 12 | $155 |
| Metoprolol Tartrate | 18 | $90 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 13 | $85 |
| Sertraline Hcl | 16 | $59 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Willard
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.